Seong-Keun Hong, Ki-Hyun Cho, Jung-Hoon Kwon, Da-Won Kim, Jongho Kim, Da-Young Kim, Hae-Eun Kang, Jong-Soo Lee, Yeon-Hee Kim
{"title":"Pathological Characterization of African Swine Fever Viruses With Genetic Deletions Detected in South Korea","authors":"Seong-Keun Hong, Ki-Hyun Cho, Jung-Hoon Kwon, Da-Won Kim, Jongho Kim, Da-Young Kim, Hae-Eun Kang, Jong-Soo Lee, Yeon-Hee Kim","doi":"10.1155/tbed/9917280","DOIUrl":null,"url":null,"abstract":"<div>\n <p>African swine fever virus (ASFV) genotype II has been circulating in South Korea, causing substantial economic losses to the Korean pig industry since 2019. Genetic epidemiological investigations using whole-genome sequencing have been conducted to track the genetic evolution of ASFV. Two ASFV strains were detected in domestic pig farms in South Korea, one with a large deletion in the MGF 360-6L gene and the other in the MGF 360-21R gene. Phylogenetic analysis indicated that all Korean isolates belonged to the Asian subgroup of ASFV genotype II and were further divided into distinct subclusters of Korean African swine fever (ASF) group I. To identify the pathological changes caused by the deletion of MGF 360-6L and MGF 360-21R genes, we evaluated their pathogenicity in experimentally infected domestic pigs. No significant changes in pathogenicity were observed compared to other viruses evaluated in our previous studies. All inoculated pigs died 7–10 days post-inoculation (dpi), showing acute forms of illness with common pathological lesions. These results highlight that large genetic deletions can occur naturally in ASFV, but the deletions in MGF 360-6L and MGF 360-21R genes did not alter pathogenicity in domestic pigs. Further research is needed to understand the roles of these genes, especially in viral replication and pathogenicity in wild boars and ticks.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/9917280","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/9917280","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
African swine fever virus (ASFV) genotype II has been circulating in South Korea, causing substantial economic losses to the Korean pig industry since 2019. Genetic epidemiological investigations using whole-genome sequencing have been conducted to track the genetic evolution of ASFV. Two ASFV strains were detected in domestic pig farms in South Korea, one with a large deletion in the MGF 360-6L gene and the other in the MGF 360-21R gene. Phylogenetic analysis indicated that all Korean isolates belonged to the Asian subgroup of ASFV genotype II and were further divided into distinct subclusters of Korean African swine fever (ASF) group I. To identify the pathological changes caused by the deletion of MGF 360-6L and MGF 360-21R genes, we evaluated their pathogenicity in experimentally infected domestic pigs. No significant changes in pathogenicity were observed compared to other viruses evaluated in our previous studies. All inoculated pigs died 7–10 days post-inoculation (dpi), showing acute forms of illness with common pathological lesions. These results highlight that large genetic deletions can occur naturally in ASFV, but the deletions in MGF 360-6L and MGF 360-21R genes did not alter pathogenicity in domestic pigs. Further research is needed to understand the roles of these genes, especially in viral replication and pathogenicity in wild boars and ticks.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.